The MedicX Fund Limited Total voting rights (5640L)

TIDMMXF

RNS Number : 5640L

The MedicX Fund Limited

03 October 2016

For immediate release

3 October 2016

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Total voting rights

In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, the total number of ordinary shares of the Company in issue as at 30 September 2016 was 388,066,844 (excluding treasury shares) with each share holding one voting right.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure and Transparency Rules.

The Company also holds 8,185,338 ordinary shares in treasury and has 21,981,109 ordinary shares of no par value remaining under its block listing facility.

End

For further information please contact:

   MedicX Fund                                                                  [phone] 

David Staples, Chairman

   Octopus Healthcare Group                                               [phone] 

Mike Adams, Chief Executive Officer

   Buchanan                                                                      [phone] 

Charles Ryland/Vicky Hayns

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", "MedicX Fund", "the Fund" or "the Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 152 properties.

The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is part of the Octopus Healthcare group. Octopus Healthcare invests in and develops properties as well as creating partnerships to deliver innovative healthcare buildings to improve the health, wealth and wellbeing of the UK. It currently manages over GBP1 billion of healthcare investments across a number of platforms, with a focus on four core areas: GP surgeries, care homes, retirement housing and private hospitals. Octopus Healthcare is part of the Octopus group, a fast-growing UK fund management business with leading positions in several specialist sectors including healthcare property, energy, property finance and smaller company investing. Octopus manages GBP5.5 billion of funds for more than 50,000 retail and institutional investors.

Octopus Healthcare Adviser Ltd is authorised and regulated by the Financial Conduct Authority.

The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

This information is provided by RNS

The company news service from the London Stock Exchange

END

TVRUGGPWUUPQGQW

(END) Dow Jones Newswires

October 03, 2016 12:45 ET (16:45 GMT)